List of insiders holdings for PROTEIN DESIGN LABS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Silver Point Capital L.P. O'Shea Robert J MULE EDWARD A 10% Owner |
2021-02-03 17:57:54 | 23,970,334 0 |
23,970,334 | Form 4 |
2 | Park West Asset Management LLC 10% Owner |
2021-01-11 16:32:37 | 0 14,397,212 |
14,397,212 | Form 3 |
3 | QUEEN CARY L Director |
2005-12-28 12:01:20 | 1,991,800 17,600 |
2,009,400 | Form 4 |
4 | Hasnain Faheem President & CEO |
2008-10-03 10:56:22 | 775,000 0 |
775,000 | Form 4 |
5 | Monnet Dominique President and CEO |
2020-12-17 16:48:55 | 734,921 0 |
734,921 | Form 4 |
6 | GARCIA PETER S Vice President, CFO |
2019-04-16 17:16:40 | 641,025 0 |
641,025 | Form 4/A |
7 | SAXE JON S Director |
2008-04-10 10:41:21 | 421,680 0 |
421,680 | Form 4 |
8 | Stone Christopher Lewis VP, Gen. Counsel & Secretary |
2020-12-17 16:49:14 | 405,559 0 |
405,559 | Form 4 |
9 | Hart Danny J Jr. VP Business Development |
2017-03-07 20:18:11 | 387,236 0 |
387,236 | Form 4 |
10 | Imbrogno Edward VP Finance, CAO and Acting CFO |
2020-04-07 08:47:46 | 314,565 0 |
314,565 | Form 4/A |
11 | Lindell Jody S Director |
2018-06-12 16:30:20 | 256,174 0 |
256,174 | Form 4 |
12 | Edick Paul R Director |
2018-06-12 16:29:50 | 214,563 0 |
214,563 | Form 4 |
13 | MCLAUGHLIN JOHN PETER Director |
2020-12-22 19:51:33 | 200,000 0 |
200,000 | Form 4 |
14 | Jene Jill M. VP, Business Development |
2020-04-07 08:46:58 | 194,805 0 |
194,805 | Form 4/A |
15 | Hernday Natasha Director |
2020-08-24 06:06:26 | 194,497 0 |
194,497 | Form 4 |
16 | Pietzke Steffen VP, Finance and CAO |
2017-12-19 20:03:53 | 139,587 20,590 |
160,177 | Form 4 |
17 | Saks Samuel R Director |
2019-06-24 21:40:43 | 126,050 0 |
126,050 | Form 4 |
18 | Yanai Shlomo Director |
2019-06-24 21:44:19 | 126,050 0 |
126,050 | Form 4 |
19 | Sandman Paul W Director |
2019-06-24 21:36:13 | 126,050 0 |
126,050 | Form 4 |
20 | SELICK HAROLD E Director |
2019-06-24 21:39:28 | 126,050 0 |
126,050 | Form 4 |
21 | SATO GLEN Y SVP and CFO |
2005-05-26 17:26:57 | 116,738 0 |
116,738 | Form 4 |
22 | KLEIN JOSEPH III Director |
2009-11-06 13:29:22 | 109,899 11 |
109,910 | Form 4 |
23 | NAJAFI BEHROOZ V.P. IS and Corporate Services |
2003-07-29 20:02:56 | 100,000 0 |
100,000 | Form 4 |
24 | Hora Maninder VP of Product Operations |
2008-08-20 15:57:05 | 84,657 0 |
84,657 | Form 3 |
25 | MURRAY RICHARD EVP & CSO |
2008-07-22 18:06:37 | 70,159 0 |
70,159 | Form 4 |
26 | JUE GEORGE VP of Finance |
2006-11-16 16:25:09 | 64,501 0 |
64,501 | Form 4 |
27 | LARSON CHRISTINE R Vice President and CFO |
2011-05-25 20:20:53 | 62,049 0 |
62,049 | Form 4 |
28 | EBERSOLE DOUGLAS O SVP, Legal & Corp. Dev. |
2004-07-26 18:15:55 | 50,000 0 |
50,000 | Form 4 |
29 | MCDADE MARK CEO |
2007-07-24 17:38:38 | 46,275 0 |
46,275 | Form 4 |
30 | TORRES LAURIE C VP, Corporate Services |
2007-04-17 14:59:35 | 44,072 0 |
44,072 | Form 4 |
31 | FRANK FRED Director |
2012-06-06 18:24:00 | 33,296 0 |
33,296 | Form 4 |
32 | BENNER STEVEN E SVP & Chief Med. Off. |
2006-07-24 18:26:43 | 28,427 0 |
28,427 | Form 4 |
33 | OLSON LYN D VP, Quality & Compliance |
2004-07-26 18:44:43 | 27,000 0 |
27,000 | Form 4 |
34 | Montez David Controller and CAO |
2015-01-30 16:02:32 | 26,719 0 |
26,719 | Form 4 |
35 | Broder Samuel Director |
2007-06-22 17:32:06 | 26,500 0 |
26,500 | Form 4 |
36 | Goodwin Bradford S Chairperson of the Board |
2008-07-17 17:26:03 | 25,000 0 |
25,000 | Form 4 |
37 | GARCIA RODRIGUEZ SERGIO VP, Legal and General Counsel |
2004-07-26 19:39:03 | 25,000 0 |
25,000 | Form 4 |
38 | KORN LAURENCE JAY Director |
2008-05-30 18:07:48 | 24,000 0 |
24,000 | Form 4 |
39 | GAGE L PATRICK Interim CEO |
2008-04-30 14:22:04 | 19,555 0 |
19,555 | Form 4 |
40 | Tomlinson Bruce Chief Financial Officer |
2012-06-21 18:41:58 | 16,509 0 |
16,509 | Form 4 |
41 | SHAH JAISIM SVP, Mktg & Bus. Affairs |
2008-04-30 14:25:56 | 16,125 0 |
16,125 | Form 4 |
42 | McCamish Mark Anthony SVP & CMO |
2008-12-19 14:31:12 | 14,924 0 |
14,924 | Form 4 |
43 | SCHMIDLI BRETT L SVP, Technical Operations |
2005-09-08 18:40:07 | 14,500 0 |
14,500 | Form 4 |
44 | GOULD GEORGE M Director |
2004-07-01 20:22:08 | 14,000 0 |
14,000 | Form 4 |
45 | GUGGENHIME ANDREW SVP & Chief Financial Officer |
2008-12-19 12:48:13 | 13,255 0 |
13,255 | Form 4 |
46 | WILSON KAREN J VP of Finance & PAO |
2009-05-11 13:20:53 | 10,494 0 |
10,494 | Form 4 |
47 | Bazaar Alan Lee Director |
2020-11-20 20:22:02 | 10,438 0 |
10,438 | Form 4 |
48 | CHARLSON FRANCES G VP, Human Resources |
2003-07-01 17:39:15 | 10,000 0 |
10,000 | Form 4 |
49 | BENJAMIN WILLIAM R VP, Research & Clinical Tech |
2003-07-01 17:10:22 | 10,000 0 |
10,000 | Form 4 |
50 | Savel Robert Michael II SVP Technical Operations |
2007-08-17 17:46:47 | 10,000 0 |
10,000 | Form 4 |
51 | Shumate Cynthia Lynn VP Legal Affrs, Secy & CCO |
2007-08-17 17:53:52 | 10,000 0 |
10,000 | Form 4 |
52 | KRUMEL CAROLINE J VPFinance/Prin.Accting Officer |
2012-01-20 18:00:15 | 9,384 0 |
9,384 | Form 4 |
53 | BACKER MARK P VP, Technical Development |
2003-07-01 16:55:30 | 7,500 0 |
7,500 | Form 4 |
54 | KLINGBELL CORINE VP, Preclinical Development |
2003-07-01 18:06:24 | 7,500 0 |
7,500 | Form 4 |
55 | Sarena Francis Willard VP/Gen Counsel/Secy |
2008-09-17 11:44:41 | 5,756 0 |
5,756 | Form 4 |
56 | CROSS HERB Corp Controller/Prin Acctg Off |
2008-09-17 11:43:26 | 5,031 0 |
5,031 | Form 4 |
57 | LINK MAX Director |
2006-12-22 18:51:57 | 5,000 0 |
5,000 | Form 4 |
58 | CALDWELL PATRICK M VP, Finance and Controller |
2003-07-01 17:30:05 | 5,000 0 |
5,000 | Form 4 |
59 | LYONS GARY A Director |
2008-08-15 16:23:59 | 2,500 0 |
2,500 | Form 4 |
60 | DAWES KAREN A Chairperson of the Board |
2008-04-30 14:27:35 | 2,250 0 |
2,250 | Form 4 |
61 | Calcott Peter H VP, Quality & Compliance |
2007-01-29 19:00:41 | 1,875 0 |
1,875 | Form 4 |
62 | GRYSKA DAVID W Director |
2020-12-31 18:48:57 | 1,387 0 |
1,387 | Form 4 |
63 | Immune Response BioPharma Inc. Shareholder |
2015-06-24 18:20:19 | 1 0 |
1 | Form 3 |
64 | Iwanicki David VP, Sales & Sales Operations |
2008-01-03 13:32:13 | 0 0 |
0 | Form 4 |
65 | O'Farrell Elizabeth G. Director |
2020-11-24 19:25:36 | 0 0 |
0 | Form 4 |
66 | DREWS JURGEN Director |
2004-06-08 20:30:27 | 0 0 |
0 | Form 4 |